SCHEMBL4768757

SCHEMBL4768757

O=S(=O)(NCCNc1cc(-c2cccnc2)nc(-c2ccccn2)n1)c1ccc(Br)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PKM P14618 3/20 0.44
ALDH1A1 P00352 3/20 0.44
L3MBTL1 Q9Y468 2/20 0.44
MEN1 O00255 1/20 0.44
KMT2A Q03164 1/20 0.44
MAPK14 Q16539 3/20 0.44
CYP3A4 P08684 1/20 0.43
CYP2C9 P11712 1/20 0.43
PTGS1 P23219 1/20 0.42
PTGS2 P35354 1/20 0.42
TBXAS1 P24557 1/20 0.41
SMN1; SMN2 Q16637 3/20 0.41
NPC1 O15118 1/20 0.41
TP53 P04637 1/20 0.41
TSHR P16473 1/20 0.41
RAB9A P51151 1/20 0.41
CYP2A6 P11509 1/20 0.41
HMOX1 P09601 1/20 0.41
PPP1CA P62136 1/20 0.40
POLB P06746 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2239971 0.80 SMN1; SMN2 (0.53) PKMALDH1A1L3MBTL1MEN1KMT2A
SCHEMBL2241291 0.79 KMT2A (0.46) PKMALDH1A1L3MBTL1MEN1KMT2A
SCHEMBL4773622 0.78 CYP2A6 (0.46) PKMALDH1A1L3MBTL1CYP3A4CYP2C9
SCHEMBL4771978 0.78 PTGDR (0.51) ALDH1A1L3MBTL1MEN1KMT2ACYP3A4
SCHEMBL4768768 0.78 PTGDR (0.53) ALDH1A1L3MBTL1MAPK14CYP3A4CYP2C9
SCHEMBL2238098 0.77 PTGDR (0.53) PKMALDH1A1L3MBTL1KMT2ACYP3A4
SCHEMBL2240945 0.77 GBA1 (0.54) PKMALDH1A1L3MBTL1CYP3A4CYP2C9
SCHEMBL2237320 0.75 HIF1A (0.47) PKMALDH1A1L3MBTL1CYP3A4CYP2C9
SCHEMBL4775842 0.74 CYP3A4 (0.60) ALDH1A1L3MBTL1CYP3A4CYP2C9SMN1; SMN2
SCHEMBL4771527 0.74 CYP3A4 (0.55) PKMALDH1A1L3MBTL1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1878733-A1 Pyrimidine derivatives as ALK-5 inhibitors Novartis AG (CH) 2008-01-16 EP disclosed